0001209191-21-039228.txt : 20210609 0001209191-21-039228.hdr.sgml : 20210609 20210609172447 ACCESSION NUMBER: 0001209191-21-039228 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210608 FILED AS OF DATE: 20210609 DATE AS OF CHANGE: 20210609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lawton Alison Frances CENTRAL INDEX KEY: 0001542650 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37722 FILM NUMBER: 211006051 MAIL ADDRESS: STREET 1: 39 ROBINSON ROAD CITY: LEXINGTON STATE: MA ZIP: 02420 FORMER NAME: FORMER CONFORMED NAME: LAWTON ALISON FRANCIS DATE OF NAME CHANGE: 20120216 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aeglea BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001636282 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464312787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 805 LAS CIMAS PARKWAY STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: (512) 942-2935 MAIL ADDRESS: STREET 1: 805 LAS CIMAS PARKWAY STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-08 0 0001636282 Aeglea BioTherapeutics, Inc. AGLE 0001542650 Lawton Alison Frances C/O AEGLEA BIOTHERAPEUTICS, INC. 805 LAS CIMAS PARKWAY, SUITE 100 AUSTIN TX 78746 1 0 0 0 Director Stock Option (right to buy) 6.80 2021-06-08 4 A 0 40000 0.00 A 2031-06-07 Common Stock 40000 40000 D The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 8, 2021, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date. /s/ Joey Perrone, by power of attorney 2021-06-09